Genetic variation of CHRNA4 does not modulate attention in Parkinson's disease

Neuroscience Letters

Volumn 479, Issue 2, 2010, Pages 123-125

  Hudson, Gavin ^a   Stutt, Andrea ^b   Eccles, Martin ^b   Robinson, Louise ^b   Allcock, Liesl M ^b   Wesnes, Keith A ^c   Chinnery, Patrick F ^a,b   Burn, David J ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c NONE   (United Kingdom)

Author keywords

Ageing; Attention; Cholinergic receptor; Parkinson's disease

Indexed keywords

NICOTINIC RECEPTOR ALPHA4; NICOTINIC ACETYLCHOLINE RECEPTOR ALPHA4 SUBUNIT; NICOTINIC RECEPTOR;

AGED; ARTICLE; ATTENTION DEFICIT DISORDER; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; FEMALE; GENE FREQUENCY; GENETIC LINKAGE; GENETIC VARIABILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MINI MENTAL STATE EXAMINATION; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ATTENTION; CASE CONTROL STUDY; GENETIC POLYMORPHISM; GENETICS; PSYCHOLOGY; REACTION TIME;

AGED; ATTENTION; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; MALE; PARKINSON DISEASE; POLYMORPHISM, GENETIC; REACTION TIME; RECEPTORS, NICOTINIC;

EID: 77953911301     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.05.041     Document Type: Article

References (11)

1. Ballard C.G., Stephens S., McLaren A., Wesnes K., Kenny R.A., Burton E., O'Brien J., Kalaria R. Neuropsychological deficits in older stroke patients. Ann. N. Y. Acad. Sci. 2002, 977:179-182.
2. Bohnen N.I., Kaufer D.I., Hendrickson R., Ivanco L.S., Lopresti B.J., Constantine G.M., Mathis C.A., Davis J.G., Moore R.Y., Dekosky S.T. Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia. J. Neurol. 2006, 253:242-247.
3. Emre M., Aarsland D., Albanese A., Byrne E.J., Deuschl G., De Deyn P.P., Durif F., Kulisevsky J., van Laar T., Lees A., Poewe W., Robillard A., Rosa M.M., Wolters E.C., Quarg P., Tekin S., Lane R. Rivastigmine for dementia associated with Parkinson's disease. N. Engl. J. Med. 2004, 351:2509-2518.
4. Espeseth T., Greenwood P.M., Reinvang I., Fjell A.M., Walhovd K.B., Westlye L.T., Wehling E., Lundervold A., Rootwelt H., Parasuraman R. Interactive effects of APOE and CHRNA4 on attention and white matter volume in healthy middle-aged and older adults. Cogn. Affect Behav. Neurosci. 2006, 6:31-43.
5. Greenwood P.M., Fossella J.A., Parasuraman R. Specificity of the effect of a nicotinic receptor polymorphism on individual differences in visuospatial attention. J. Cogn. Neurosci. 2005, 17:1611-1620.
6. Hughes A.J., Colosimo C., Kleedorfer B., Daniel S.E., Lees A.J. The dopaminergic response in multiple system atrophy, Journal of Neurology. Neurosurg. Psychiatry 1992, 55:1009-1013.
7. Reinvang I., Lundervold A.J., Rootwelt H., Wehling E., Espeseth T. Individual variation in a cholinergic receptor gene modulates attention. Neurosci. Lett. 2009, 453:131-134.
8. Roth M., Tym E., Mountjoy C.Q., Huppert F.A., Hendrie H., Verma S., Goddard R. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br. J. Psychiatry 1986, 149:698-709.
9. Salthouse T.A. The processing-speed theory of adult age differences in cognition. Psychol. Rev. 1996, 103:403-428.
10. Tiraboschi P., Hansen L.A., Alford M., Sabbagh M.N., Schoos B., Masliah E., Thal L.J., Corey-Bloom J. Cholinergic dysfunction in diseases with Lewy bodies. Neurology 2000, 54:407-411.
11. Wesnes K.A., McKeith I., Edgar C., Emre M., Lane R. Benefits of rivastigmine on attention in dementia associated with Parkinson disease. Neurology 2005, 65:1654-1656.